Immunomodulatory Therapies for Interstitial Cystitis/Bladder Pain Syndrome

No abstract is available for this paper.

• Publication year

  2020

• Venue

  Current Bladder Dysfunction Reports

• Publication date

  2020-05-29

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s11884-020-00593-1
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Hunner Lesion Phenotype in Interstitial Cystitis/Bladder Pain Syndrome: A Systematic Review and Meta-Analysis.

  2020cited by this paper
• Interstitial cystitis/bladder pain syndrome: The evolving landscape, animal models and future perspectives

  2020cited by this paper
• Pathology and terminology of interstitial cystitis/bladder pain syndrome: A review.

  2019cited by this paper
• Molecular Taxonomy of Interstitial Cystitis/Bladder Pain Syndrome Based on Whole Transcriptome Profiling by Next-Generation RNA Sequencing of Bladder Mucosal Biopsies.

  2019cited by this paper
• Phenotyping of interstitial cystitis/bladder pain syndrome

  2019cited by this paper
• Electron microscopic characteristics of interstitial cystitis/bladder pain syndrome and their association with clinical condition

  2018cited by this paper
• Digital quantitative analysis of mast cell infiltration in interstitial cystitis

  2018cited by this paper
• A Randomized, Double-blind, Placebo-controlled Trial of Certolizumab Pegol in Women with Refractory Interstitial Cystitis/Bladder Pain Syndrome.

  2018cited by this paper
• Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience

  2017cited by this paper
• Efficacy, Side Effects, and Monitoring of Oral Cyclosporine in Interstitial Cystitis-Bladder Pain Syndrome.

  2017cited by this paper
• Pain relief after triamcinolone infiltration in patients with bladder pain syndrome with Hunner’s ulcers

  2017cited by this paper
• Increased CXCR3 Expression of Infiltrating Plasma Cells in Hunner Type Interstitial Cystitis

  2016cited by this paper
• Clinical Phenotyping Does Not Differentiate Hunner Lesion Subtype of Interstitial Cystitis/Bladder Pain Syndrome: A Relook at the Role of Cystoscopy.

  2016cited by this paper
• Clinical guidelines for interstitial cystitis and hypersensitive bladder updated in 2015

  2016cited by this paper
• Exploring BAFF: its expression, receptors and contribution to the immunopathogenesis of Sjögren's syndrome.

  2016cited by this paper
• The Role of Glomerulations in Bladder Pain Syndrome: A Review.

  2016cited by this paper
• Interstitial cystitis associated with primary Sjögren's syndrome successfully treated with a combination of tacrolimus and corticosteroid: A case report and literature review

  2016cited by this paper
• Are mast cells still good biomarkers for bladder pain syndrome/interstitial cystitis?

  2015cited by this paper
• Efficacy and safety of belimumab in primary Sjögren's syndrome: results of the BELISS open-label phase II study.

  2015cited by this paper
• Hunner-Type (Classic) Interstitial Cystitis: A Distinct Inflammatory Disorder Characterized by Pancystitis, with Frequent Expansion of Clonal B-Cells and Epithelial Denudation

  2015cited by this paper
• Biological phenotypes underpin the physio‐somatic symptoms of somatization, depression, and chronic fatigue syndrome

  2014cited by this paper
• Herpes simplex virus vector mediated gene therapy of tumor necrosis factor-α blockade for bladder overactivity and nociception in rats.

  2013cited by this paper
• Increased mRNA expression of genes involved in pronociceptive inflammatory reactions in bladder tissue of interstitial cystitis.

  2013cited by this paper
• Differences in mast cell infiltration, E-cadherin, and zonula occludens-1 expression between patients with overactive bladder and interstitial cystitis/bladder pain syndrome.

  2012cited by this paper
• The combination therapy of prednisolone and tacrolimus for severe painful bladder syndrome/interstitial cystitis.

  2012cited by this paper
• Cyclosporine A for refractory interstitial cystitis/bladder pain syndrome: experience of 3 tertiary centers.

  2012cited by this paper
• Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial.

  2011cited by this paper
• Early termination of a trial of mycophenolate mofetil for treatment of interstitial cystitis/painful bladder syndrome: lessons learned.

  2011cited by this paper
• Are ulcerative and nonulcerative interstitial cystitis/painful bladder syndrome 2 distinct diseases? A study of coexisting conditions.

  2011cited by this paper
• AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome.

  2011cited by this paper
• Antecedent nonbladder syndromes in case-control study of interstitial cystitis/painful bladder syndrome.

  2009cited by this paper
• Assessment of patient outcomes following submucosal injection of triamcinolone for treatment of Hunner's ulcer subtype interstitial cystitis.

  2009cited by this paper
• Genomic and nongenomic effects of glucocorticoids

  2008cited by this paper
• Cyclosporine (CsA) in lupus nephritis: assessing the evidence.

  2008cited by this paper
• Uroplakin III-delta4 messenger RNA as a promising marker to identify nonulcerative interstitial cystitis.

  2007cited by this paper
• Efficacy of prednisone for severe refractory ulcerative interstitial cystitis.

  2005cited by this paper
• Cyclosporine A and pentosan polysulfate sodium for the treatment of interstitial cystitis: a randomized comparative study.

  2005cited by this paper
• Possible mechanisms inducing glomerulations in interstitial cystitis: relationship between endoscopic findings and expression of angiogenic growth factors.

  2004cited by this paper
• Long-term outcome of patients with interstitial cystitis treated with low dose cyclosporine A.

  2004cited by this paper
• Primary evaluation of patients suspected of having interstitial cystitis (IC).

  2004cited by this paper
• [Discovery and development of a novel immunosuppressant, tacrolimus hydrate].

  1997cited by this paper
• Cyclosporine in severe interstitial cystitis.

  1996cited by this paper
• Epithelial dysfunction in nonbacterial cystitis (interstitial cystitis).

  1991cited by this paper
• Immunoglobulin deposits in bladder epithelium and vessels in interstitial cystitis: possible relationship to circulating anti-intermediate filament autoantibodies.

  1984cited by this paper

• Lipidomic analysis coupled with machine learning identifies unique urinary lipid signatures in patients with interstitial cystitis/bladder pain syndrome

  2025cites this paper